Anglia Ruskin Research Online (ARRO)
Browse
DOCUMENT
Ghayda_et_al_2020.docx (189.58 kB)
DOCUMENT
Ghayda_et_al_2020.pdf (1.04 MB)
1/0
2 files

COVID-19 and adverse pregnancy outcome: a systematic review of 104 cases

journal contribution
posted on 2023-08-30, 17:43 authored by Ramy A. Ghayda, Han Li, Keum Hwa Lee, Hee Won Lee, Sung Hwi Hong, Moonsu Kwak, Minwoo Lee, Minjae Kwon, Ai Koyanagi, Andreas Kronbichler, Louis Jacob, Lee Smith, Jae Il Shin
(1) Background: Until now, several reports about pregnant women with confirmed coronavirus disease 2019 (COVID-19) have been published. However, there are no comprehensive systematic reviews collecting all case series studies on data regarding adverse pregnancy outcomes, especially association with treatment modalities. (2) Objective: We aimed to synthesize the most up-to-date and relevant available evidence on the outcomes of pregnant women with laboratory-confirmed infection with COVID-19. (3) Methods: PubMed, Scopus, MEDLINE, Google scholar, and Embase were explored for studies and papers regarding pregnant women with COVID-19, including obstetrical, perinatal, and neonatal outcomes and complications published from 1 January 2020 to 4 May 2020. Systematic review and search of the published literature was done using the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA). (4) Results: In total, 11 case series studies comprising 104 pregnant women with COVID-19 were included in our review. Fever (58.6%) and cough (30.7%) were the most common symptoms. Other symptoms included dyspnea (14.4%), chest discomfort (3.9%), sputum production (1.0%), sore throat (2.9%), and nasal obstruction (1.0%). Fifty-two patients (50.0%) eventually demonstrated abnormal chest CT, and of those with ground glass opacity (GGO), 23 (22.1%) were bilateral and 10 (9.6%) were unilateral. The most common treatment for COVID-19 was administration of antibiotics (25.9%) followed by antivirals (17.3%). Cesarean section was the mode of delivery for half of the women (50.0%), although no information was available for 28.8% of the cases. Regarding obstetrical and neonatal outcomes, fetal distress (13.5%), pre-labor rupture of membranes (9.6%), prematurity (8.7%), fetal death (4.8%), and abortion (2.9%) were reported. There are no positive results of neonatal infection by RT-PCR. (5) Conclusions: Although we have found that pregnancy with COVID-19 has significantly higher maternal mortality ratio compared to that of pregnancy without the disease, the evidence is too weak to state that COVID-19 results in poorer maternal outcome due to multiple factors. The number of COVID-19 pregnancy outcomes was not large enough to draw a conclusion and long-term outcomes are yet to be determined as the pandemic is still unfolding. Active and intensive follow-up is needed in order to provide robust data for future studies.

History

Refereed

  • Yes

Volume

9

Issue number

11

Page range

3441

Publication title

Journal of Clinical Medicine

ISSN

2077-0383

Publisher

MDPI

File version

  • Accepted version

Language

  • eng

Legacy posted date

2020-09-29

Legacy creation date

2020-09-29

Legacy Faculty/School/Department

COVID-19 Research Collection

Usage metrics

    ARU Outputs

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC